Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations

A. Slomka; M. Kowalewski; E. Zekanowska

doi:10.3390/pathogens9060493

Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations

A. Slomka^*, M. Kowalewski, E. Zekanowska

^*Corresponding author for this work

Carim - Surgical intervention

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID-19). Elucidating the changes in hematological parameters in SARS-CoV-2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.

Original language	English
Article number	493
Number of pages	18
Journal	Pathogens
Volume	9
Issue number	6
DOIs	https://doi.org/10.3390/pathogens9060493
Publication status	Published - 1 Jun 2020

Keywords

BIOMARKER
COAGULATION
ERYTHROCYTE SEDIMENTATION-RATE
INFECTION
INFLAMMATION
MANAGEMENT
PNEUMONIA
biomarker
coagulation
coronavirus disease 2019 COVID-19
coronavirus disease 2019 covid-19
cytokine storm
erythrocyte sedimentation-rate
hematology
hemostasis
infection
pneumonia
severe acute respiratory syndrome coronavirus 2 SARS-CoV-2
severe acute respiratory syndrome coronavirus 2 sars-cov-2

Access to Document

10.3390/pathogens9060493Licence: CC BY

Cite this

@article{338200791082456691d9c8a099e43a33,

title = "Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations",

abstract = "Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID-19). Elucidating the changes in hematological parameters in SARS-CoV-2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.",

keywords = "BIOMARKER, COAGULATION, ERYTHROCYTE SEDIMENTATION-RATE, INFECTION, INFLAMMATION, MANAGEMENT, PNEUMONIA, biomarker, coagulation, coronavirus disease 2019 COVID-19, coronavirus disease 2019 covid-19, cytokine storm, erythrocyte sedimentation-rate, hematology, hemostasis, infection, pneumonia, severe acute respiratory syndrome coronavirus 2 SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 sars-cov-2",

author = "A. Slomka and M. Kowalewski and E. Zekanowska",

year = "2020",

month = jun,

day = "1",

doi = "10.3390/pathogens9060493",

language = "English",

volume = "9",

journal = "Pathogens",

issn = "2076-0817",

publisher = "MDPI",

number = "6",

}

TY - JOUR

T1 - Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations

AU - Slomka, A.

AU - Kowalewski, M.

AU - Zekanowska, E.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID-19). Elucidating the changes in hematological parameters in SARS-CoV-2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.

AB - Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID-19). Elucidating the changes in hematological parameters in SARS-CoV-2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.

KW - BIOMARKER

KW - COAGULATION

KW - ERYTHROCYTE SEDIMENTATION-RATE

KW - INFECTION

KW - INFLAMMATION

KW - MANAGEMENT

KW - PNEUMONIA

KW - biomarker

KW - coagulation

KW - coronavirus disease 2019 COVID-19

KW - coronavirus disease 2019 covid-19

KW - cytokine storm

KW - erythrocyte sedimentation-rate

KW - hematology

KW - hemostasis

KW - infection

KW - pneumonia

KW - severe acute respiratory syndrome coronavirus 2 SARS-CoV-2

KW - severe acute respiratory syndrome coronavirus 2 sars-cov-2

U2 - 10.3390/pathogens9060493

DO - 10.3390/pathogens9060493

M3 - (Systematic) Review article

C2 - 32575786

SN - 2076-0817

VL - 9

JO - Pathogens

JF - Pathogens

IS - 6

M1 - 493

ER -

Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations

Abstract

Keywords

Access to Document

Fingerprint

Cite this